Systemic complement profiling in multiple sclerosis as a biomarker of disease state

por Ingram, G, Hakobyan, S, Hirst, CL, Harris, CL, Loveless, S, Mitchell, JP, Pickersgill, TP, Robertson, NP, Morgan, BP
Publicado 2012

Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies

por Beesley, R., Cauchi, M., Davies, L., Upcott, M., Norton, E., Loveless, S., Anderson, V., Wynford-Thomas, R., Pickersgill, T.P., Uzochukwu, E., Wardle, M., Robertson, N.P., Tallantyre, E., Willis, M.D.
Publicado 2022